Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

Detalles Bibliográficos
Autores principales: Groen, Kazimierz, Schjesvold, Fredrik H., van der Holt, Bronno, Levin, Mark-David, Seefat, Maarten R., Hansson, Markus, Leys, Maria B.L., Regelink, Josien C., Waage, Anders, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Svirskaite, Asta, van der Spek, Ellen, Haukas, Einar, Knut-Bojanowska, Dorota, Ypma, Paula F., Blimark, Cecilie H., Mellqvist, Ulf-Henrik, van de Donk, Niels W.C.J., Sonneveld, Pieter, Klostergaard, Anja, Vangsted, Annette J., Abildgaard, Niels, Zweegman, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470677/
https://www.ncbi.nlm.nih.gov/pubmed/37663673
http://dx.doi.org/10.1097/HS9.0000000000000940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470677/
https://www.ncbi.nlm.nih.gov/pubmed/37663673
http://dx.doi.org/10.1097/HS9.0000000000000940

Ejemplares similares